Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
is supported by the Canada Research Chair Program, a BBDC-Novo Nordisk Chair and CIHR grant 123391 and 154321
A one-month trial may produce initial appetite suppression, yet most clinical evidence supports longer treatment windows to see significant, stable weight reduction and metabolic benefits
Eli Lillys Direct-to-Employer Platform On March 5, 2026, Eli Lilly officially launched Lilly Employer Connect, a program giving employers a direct route to offer Zepbound to their employees at the $449 direct-to-employer price, completely outside the traditional insurance and PBM channel
10.1016/j.lfs.2011.12.001 143
US$ 23.26
US$ 24.64
US$ 26.42
US$ 28.16
